Back to History

Fields Changed

Registration

Field Before After
Trial Status in_development on_going
Trial Start Date December 01, 2019 August 15, 2020
Last Published November 22, 2019 10:05 PM September 09, 2020 03:30 PM
Intervention Start Date December 01, 2019 August 15, 2020
Primary Outcomes (End Points) Duration of abstinence as measured by in-clinic urinalysis Duration of abstinence as measured by in-clinic urinalysis, percentage of urine drug tests negative, enrollment rates
Experimental Design (Public) To answer our research questions, we will conduct a randomized controlled trial of temporary incentives to encourage either abstinence, or inputs to abstinence, among 600 adults with opioid use disorders in Milwaukee, Wisconsin. Participants will be recruited from outpatients with substance use disorders in treatment at the Adult Behavioral Health Program within the Aurora Health Care System. Incentivized behaviors will be monitored and rewarded through a mobile application developed by our implementing technology partner, Dynamicare Management. We will evaluate the incentives using a combination of administrative data and surveys. In preparation for this experiment, we will conduct a Phase 1 pilot of 36-50 individuals to test and fine-tune our study protocols. In our pilot study, we will randomly assign individuals to either receive the mobile application to incentivize abstinence, a version of the application that has behavior monitoring but no incentives, or control. The full experimental design will be developed following this pilot. To answer our research questions, we will conduct a randomized controlled trial of temporary incentives to encourage either abstinence, or inputs to abstinence, among 600 adults with opioid use disorders in Milwaukee, Wisconsin. Participants will be recruited from outpatients with substance use disorders in treatment at the Adult Behavioral Health Program within the Aurora Health Care System. Incentivized behaviors will be monitored and rewarded through a mobile application developed by our implementing technology partner, Dynamicare Management. We will evaluate the incentives using a combination of administrative data and surveys. In preparation for this experiment, we will conduct a Phase 1 pilot of 30 individuals to test and fine-tune our study protocols. The full experimental design will be developed following this pilot.
Planned Number of Observations We aim to enroll approximately 36-50 individuals in the pilot. We aim to enroll approximately 30 individuals in the pilot.
Sample size (or number of clusters) by treatment arms The following treatment group distribution in the pilot is approximate, since enrollees will be assigned to treatments in a pre-determined order but may withdraw. Treatment Groups: T1 – Incentives: 1/3 T2 – Monitoring Only: 1/3 T3 – Control: 1/3 The following treatment group distribution in the pilot is approximate, since enrollees will be assigned to treatments in a pre-determined order but may withdraw. Treatment Groups: T1 – Inputs: 1/3 T2 – Outcomes: 1/3 T3 – Combined: 1/3
Did you obtain IRB approval for this study? No Yes
Back to top

Irbs

Field Before After
IRB Name Aurora IRB
IRB Approval Date April 30, 2020
IRB Approval Number 19-127E
Back to top

Other Primary Investigators

Field Before After
Affiliation Advocate Aurora Health
Back to top

Sponsors

Field Before After
Sponsor Name J-PAL HCDI J-PAL North America - HCDI
Public No Yes
Back to top